These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10420100)

  • 1. Receptor test (pupillary dilatation after application of 0.01% tropicamide solution) and determination of central nervous activation (Fourier analysis of pupillary oscillations) in patients with Alzheimer's disease.
    Grünberger J; Linzmayer L; Walter H; Rainer M; Masching A; Pezawas L; Saletu-Zyhlarz G; Stöhr H; Grünberger M
    Neuropsychobiology; 1999; 40(1):40-6. PubMed ID: 10420100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychophysiological diagnostics in alcohol dependency: Fourier analysis of pupillary oscillations and the receptor test for determination of cholinergic deficiency.
    Grünberger J; Linzmayer L; Walter H; Stöhr H; Saletu-Zyhlarz GM; Grünberger M; Lesch OM
    Alcohol Alcohol; 1998; 33(5):541-8. PubMed ID: 9811208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pupillary response to tropicamide in Alzheimer's disease.
    Fridh M; Havelius U; Elofsson G; Hindfelt B
    Acta Ophthalmol Scand; 1996 Jun; 74(3):276-9. PubMed ID: 8828726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tropicamide effects on pupil size and pupillary light reflexes in Alzheimer's and Parkinson's disease.
    Granholm E; Morris S; Galasko D; Shults C; Rogers E; Vukov B
    Int J Psychophysiol; 2003 Feb; 47(2):95-115. PubMed ID: 12568941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The pupillary response test as a method to differentiate various types of dementia].
    Grünberger J; Prause W; Frottier P; Stöhr H; Saletu B; Haushofer M; Rainer M
    Neuropsychiatr; 2009; 23(1):52-7. PubMed ID: 19272292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypersensitivity in the pupil dilation response to a cholinergic antagonist in patients with Alzheimer's disease and Down's syndrome].
    Kono K; Miyao M; Ishihara S; Takagi A; Ikari H; Suzuki Y; Iguchi A
    Nihon Ronen Igakkai Zasshi; 1996 Nov; 33(11):829-34. PubMed ID: 8997102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why patients with Alzheimer's disease may show increased sensitivity to tropicamide eye drops: role of locus coeruleus.
    Hou RH; Samuels ER; Raisi M; Langley RW; Szabadi E; Bradshaw CM
    Psychopharmacology (Berl); 2006 Jan; 184(1):95-106. PubMed ID: 16308726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pupillary dilatation test and Fourier analysis of pupillary oscillations in patients with multiple sclerosis.
    Grünberger J; Linzmayer L; Majda EM; Reitner A; Walter H
    Eur Arch Psychiatry Clin Neurosci; 1996; 246(4):209-12. PubMed ID: 8832199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tropicamide test in patients with dementia of Alzheimer type and frontotemporal dementia.
    Robles A; Touriño R; Gude F; Noya M
    Funct Neurol; 1999; 14(4):203-7. PubMed ID: 10713893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-evaluation of tropicamide in the pupillary response test for Alzheimer's disease.
    Iijima A; Haida M; Ishikawa N; Ueno A; Minamitani H; Shinohara Y
    Neurobiol Aging; 2003 Oct; 24(6):789-96. PubMed ID: 12927761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tropicamide eyedrops cannot be used for reliable diagnosis of Alzheimer's disease.
    Graff-Radford NR; Lin SC; Brazis PW; Bolling JP; Liesegang TJ; Lucas JA; Uitti RJ; O'Brien PC
    Mayo Clin Proc; 1997 Jun; 72(6):495-504. PubMed ID: 9179132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pupillary response to tropicamide in patients with Alzheimer disease.
    Loupe DN; Newman NJ; Green RC; Lynn MJ; WIlliams KK; Geis TC; Edelhauser HF
    Ophthalmology; 1996 Mar; 103(3):495-503. PubMed ID: 8600428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mydriatic effect of multiple doses of tropicamide.
    Siderov J; Nurse S
    Optom Vis Sci; 2005 Nov; 82(11):955-8. PubMed ID: 16317370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pupil response to tropicamide in Alzheimer's disease and other neurodegenerative disorders.
    Gómez-Tortosa E; del Barrio A; Jiménez-Alfaro I
    Acta Neurol Scand; 1996 Aug; 94(2):104-9. PubMed ID: 8891054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pupil dilation response to tropicamide: a biological test for Alzheimer's disease?
    Kurz A; Marquard R; Fremke S; Leipert KP
    Pharmacopsychiatry; 1997 Jan; 30(1):12-5. PubMed ID: 9065964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does prior instillation of a topical anaesthetic alter the pupillary mydriasis produced by tropicamide (0.5%)?
    Haddad DE; Rosenfield M; Portello JK; Krumholz DM
    Ophthalmic Physiol Opt; 2007 May; 27(3):311-4. PubMed ID: 17470245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pupillary response to tropicamide in Japanese patients with alcoholic dementia, Alzheimer's disease, and vascular dementia.
    Higuchi S; Matsushita S; Hasegawa Y; Muramatsu T; Arai H
    Exp Neurol; 1997 Mar; 144(1):199-201. PubMed ID: 9126171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combination solution for routine pupillary dilation.
    Krumholz DM; Portello JK; Rosenfield M; Rosenbaum JD
    Optometry; 2006 Jul; 77(7):350-3. PubMed ID: 16814239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pupil dilation to tropicamide is not specific for Alzheimer disease.
    Growdon JH; Graefe K; Tennis M; Hayden D; Schoenfeld D; Wray SH
    Arch Neurol; 1997 Jul; 54(7):841-4. PubMed ID: 9236572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can tropicamide eye drop response differentiate patients with progressive supranuclear palsy and Alzheimer's disease from healthy control subjects?
    Litvan I; FitzGibbon EJ
    Neurology; 1996 Nov; 47(5):1324-6. PubMed ID: 8909451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.